Precision medicine is a quickly evolving field especially in oncology along with germline cancer predisposition. Next generation sequencing via gene panels or even whole exome analysis just allows the quick and comprehensive identification of genetic variants.
However, variant annotation, as the subsequent step after NGS, is even more important to convert raw genomic information into reliable actionable and applicable clinical knowledge.
Molecular Health’s MH Guide is the first registered IVD of its kind in Europe and an expert oncology treatment decision support tool designed to help users like oncologists or pathologists by interpreting NGS data to identify better treatment options for individual cancer patients.
The focus of this seminar is to present two selected patient cases analyzed by experts from Asia and Europe that were conducted with the MH Guide software.